Kumiko Shiba

Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction

Chikara Komiya, Kyoichiro Tsuchiya, Kumiko Shiba et al. · PLoS ONE · 2016 · 227 citations · Full text

Sglt2 Inhibitor Ipragliflozin, Liver Dysfunction, Fatty Liver Disease +18

Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH

Kumiko Shiba, Kyoichiro Tsuchiya, Chikara Komiya et al. · Scientific Reports · 2018 · 172 citations · Full text

Roles for Cell-Cell Adhesion and Contact in Obesity-Induced Hepatic Myeloid Cell Accumulation and Glucose Intolerance

Yasutaka Miyachi, Kyoichiro Tsuchiya, Chikara Komiya et al. · Cell Reports · 2017 · 67 citations · Full text

Cell Adhesion, Immunology, Fatty Liver Disease +21

Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis

Chikara Komiya, Miyako Tanaka, Kyoichiro Tsuchiya et al. · Scientific Reports · 2017 · 60 citations · Full text

A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition

Yasutaka Miyachi, Kyoichiro Tsuchiya, Kumiko Shiba et al. · Scientific Reports · 2018 · 56 citations · Full text